<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04672863</url>
  </required_header>
  <id_info>
    <org_study_id>20-009762</org_study_id>
    <nct_id>NCT04672863</nct_id>
  </id_info>
  <brief_title>Mediterranean Diet Post-liver Transplantation</brief_title>
  <official_title>Effects of a Structured, Modified Mediterranean Dietary Intervention After Liver Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the effects of a structured Mediterranean dietary&#xD;
      program on prevention of weight gain, promotion of heart health and prevention of fatty liver&#xD;
      disease after liver transplantation.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Hypotheses&#xD;
&#xD;
        -  A modified Mediterranean diet after liver transplantation results in weight loss,&#xD;
           improvement of insulin sensitivity, lipid profiles, blood pressure, BMI, and waist&#xD;
           circumference in patients who adhere to the program.&#xD;
&#xD;
        -  A modified Mediterranean diet after liver transplantation results in relative&#xD;
           improvement in cardiovascular outcomes in patients who adhere to the program when&#xD;
           compared to standard of care.&#xD;
&#xD;
        -  A modified Mediterranean diet after liver transplantation results in relative&#xD;
           improvement in 10-year ASCVD risk in patients who adhere to the program when compared to&#xD;
           standard of care.&#xD;
&#xD;
        -  A modified Mediterranean diet after liver transplantation decreases the risk of&#xD;
           development of NAFLD/NASH/NASH fibrosis in patients who adhere to the program.&#xD;
&#xD;
      Study Design:&#xD;
&#xD;
        -  Single-center, prospective, randomized interventional trial&#xD;
&#xD;
        -  All eligible post-liver transplant patients during the enrollment period will be invited&#xD;
           to participate in the trial.&#xD;
&#xD;
        -  All enrolled patients will be randomized to the Dietary Intervention (DI) arm or the&#xD;
           Standard of Care (SOC) arm.&#xD;
&#xD;
        -  All patients will be followed for 12 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 19, 2021</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 14, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>weight gain</measure>
    <time_frame>4 months</time_frame>
    <description>weight in kilograms</description>
  </primary_outcome>
  <primary_outcome>
    <measure>weight gain</measure>
    <time_frame>12 months</time_frame>
    <description>weight in kilograms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>fat mass changes</measure>
    <time_frame>4 months</time_frame>
    <description>InBody body composition analysis of fat mass vs lean body mass changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fat mass changes</measure>
    <time_frame>12 months</time_frame>
    <description>InBody body composition analysis of fat mass vs lean body mass changes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Liver Transplantation</condition>
  <arm_group>
    <arm_group_label>Standard of Care Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will participate in a standardized Transplant Nutrition class between day 21-40 as per institutional protocol and will be counseled as per the Mayo Clinic standard of care vis a vis dietary intervention, standard aerobic and resistance exercise recommendations (consistent with AASLD guidelines) and other lifestyle interventions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Behavioral: Structured Modified Mediterranean Diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will participate in a one-on-one counselling session with a dietician, as opposed to attending the standardized Transplant Nutrition class. Counselling will be provided on the elements of the modified Mediterranean diet which emphasizes consumption of fruits, vegetables, whole grains, beans and nuts, in addition to low salt, moderate amounts of lean protein (primarily fish and poultry) in addition to low to moderate quantities of monounsaturated fats.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Modified Mediterranean diet approved by the Nutrition Team at the Transplant Center and it emphasizes consumption of fruits, vegetables, whole grains, beans and nuts, in addition to low salt (2-2.4g/day), moderate amounts of lean protein (primarily fish and poultry) in addition to low to moderate quantities of monounsaturated fats. The modifications to the traditional Mediterranean diet are: no alcohol consumption and fewer added fats. In addition, close scheduled followup on diet and progress with study team.</description>
    <arm_group_label>Behavioral: Structured Modified Mediterranean Diet</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Adult patients ≥ 18 years of age undergoing primary liver transplant&#xD;
&#xD;
          -  Ascites-adjusted BMI ≥ 25 kg/m2&#xD;
&#xD;
          -  Acceptable graft function (total bilirubin level &lt; 5 mg/dL and doppler ultrasound with&#xD;
             patent hepatic artery, hepatic veins and portal veins)&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Hepatocellular carcinoma (HCC) that did not fulfill Milan criteria as per explant&#xD;
             histology&#xD;
&#xD;
          -  Untreated post-transplant vascular complications or biliary strictures&#xD;
&#xD;
          -  Multi-organ transplantation&#xD;
&#xD;
          -  Urine protein excretion ≥2.0 g/day&#xD;
&#xD;
          -  Uncontrolled diabetes mellitus (HbA1c &gt; 10%)&#xD;
&#xD;
          -  Associated medical conditions incompatible with safe participation in a nutritional&#xD;
             intervention study, including digestive diseases with fat intolerance, neurological,&#xD;
             psychiatric or endocrine disorders&#xD;
&#xD;
          -  Active eating disorder (e.g. bulimia nervosa, anorexia nervosa)&#xD;
&#xD;
          -  History of bariatric surgery&#xD;
&#xD;
          -  Pregnancy or planning on pregnancy in the next year&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kymberly Watt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mohammad Qasim Khan, M.B.B.S.</last_name>
    <phone>507-284-3917</phone>
    <email>khan.mohammadqasim@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kymberly Watt, MD</last_name>
    <phone>507-266-1586</phone>
    <email>watt.kymberly@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kymberly Watt, MD</last_name>
      <phone>507-266-1586</phone>
      <email>watt.kymberly@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>December 7, 2020</study_first_submitted>
  <study_first_submitted_qc>December 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 17, 2020</study_first_posted>
  <last_update_submitted>April 7, 2021</last_update_submitted>
  <last_update_submitted_qc>April 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Kymberly D. Watt</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

